Nepal Diksha, Aryal Egesh, Parajuli Suraj, Bhattarai Ayush Mohan, Nepal Kriti, Shah Bibhant
National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
Nepalese Army Institute of Health Sciences, College of Medicine, Kathmandu, Nepal.
Ann Med Surg (Lond). 2022 Sep 20;82:104701. doi: 10.1016/j.amsu.2022.104701. eCollection 2022 Oct.
Purpura fulminans is an acute and fatal condition presenting with acute progressive hemorrhagic infarction of the skin and disseminated intravascular coagulation. Scrub typhus, is an emerging disease of Nepal, despite being a rickettsioses has been rarely associated with Purpura fulminans. The non-specific clinical presentation and limited diagnostic facility make it difficult for clinicians to diagnose the disease. Knowing the prevalence of the disease, suspecting the disease early and treatment with appropriate antibiotics can limit the course of the disease.
A 46-year-old female with no comorbidity presented with febrile illness and generalized weakness in the emergency department. During the course in hospital, she developed purpura followed by painful hemorrhagic bullae in bilateral lower limb with bluish discoloration in bilateral feet. IgM antibodies against the Orientia Tsutsugamushi antigen came out to be positive making diagnosis of purpura fulminans secondary to scrub typhus. She recovered with anti rickettsial therapy.
Purpura fulminans is an emergency condition. Scrub typhus, one of the rare cause, is diagnosed with Rickettsial DNA by PCR or by Indirect Immunofluorescence Assay (IFA) or Indirect Immunoperoxidase Assay (IPA). Medical management includes Doxycycline, fluid therapy, antipyretics and surgical management includes escharotomies and fasciotomies if required.
We feel that clinicians should be aware of rickettsia as a differential of acute febrile illness, especially when the patient presents from endemic areas. In addition to it, they should be aware of rare presentations such as purpura fulminans which can help with early suspicion of the disease and appropriate antibiotic therapy.
暴发性紫癜是一种急性致命性疾病,表现为皮肤急性进行性出血性梗死和弥散性血管内凝血。恙虫病是尼泊尔一种新出现的疾病,尽管它属于立克次体病,但很少与暴发性紫癜相关。非特异性的临床表现和有限的诊断设备使临床医生难以诊断该病。了解该病的患病率、早期怀疑该病并使用适当的抗生素进行治疗可限制疾病的病程。
一名46岁无合并症的女性因发热性疾病和全身无力就诊于急诊科。在住院期间,她出现紫癜,随后双下肢出现疼痛性出血性大疱,双足出现青紫色。抗恙虫病东方体抗原的IgM抗体呈阳性,诊断为恙虫病继发暴发性紫癜。她通过抗立克次体治疗后康复。
暴发性紫癜是一种紧急情况。恙虫病是罕见病因之一,可通过聚合酶链反应(PCR)检测立克次体DNA、间接免疫荧光试验(IFA)或间接免疫过氧化物酶试验(IPA)进行诊断。药物治疗包括多西环素、液体疗法、退烧药,手术治疗包括必要时进行焦痂切开术和筋膜切开术。
我们认为临床医生应意识到立克次体是急性发热性疾病的鉴别诊断因素,尤其是当患者来自流行地区时。此外,他们应了解暴发性紫癜等罕见表现,这有助于早期怀疑该病并进行适当的抗生素治疗。